Levin, J., Maaß, S., Schuberth, M., Giese, A., Oertel, W. H., Poewe, W., Trenkwalder, C., Wenning, G. K., Mansmann, U., Südmeyer, M., Eggert, K., Mollenhauer, B., Lipp, A., Löhle, M., Classen, J., Münchau, A., Kassubek, J., Gandor, F., Berg, D., Egert-Schwender, S., Eberhardt, C., Paul, F., Bötzel, K., Ertl-Wagner, B., Huppertz, H., Ricard, I., Höglinger, G. U., & , (2019). safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. Lancet neurology, 18(8), 724–735. http://access.bl.uk/ark:/81055/vdc_100087057089.0x000010